Newsroom
Sorted by: Latest
-
Dunham Named Finalist in the 2026 Wealthies Competition
SAN DIEGO--(BUSINESS WIRE)--Dunham & Associates Investment Counsel, Inc. (Dunham), an investment firm built for independent financial advisors by a former advisor, has been named a finalist in three categories of the 2026 Wealth Management Industry Awards, now known more simply as The Wealthies. Presented by Wealth Management, an Informa business publication serving financial professionals, The Wealthies recognizes organizations and individuals that support financial advisor success through...
-
Best Buy Reports Second Quarter Results
MINNEAPOLIS--(BUSINESS WIRE)--Best Buy Co., Inc. (NYSE: BBY) today announced results for the 13-week second quarter ended August 1, 2026 (“Q2 FY27”), as compared to the 13-week second quarter ended August 2, 2025 (“Q2 FY26”). Q2 FY27 Q2 FY26 Revenue ($ in millions) Enterprise $ 9,779 $ 9,438 Domestic segment $ 9,070 $ 8,698 International segment $ 709 $ 740 Enterprise comparable sales % change1 4.1 % 1.6 % Domestic comparable sales % change1 4.5 % 1.1 % Domestic compar...
-
TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) demonstrated statistically significant and clinically meaningful improvements across both co-primary and all key secondary endpoints at week 24, which were sustained through week 52 in both doses tested. The co-primary endpoints were histologic remission and the frequency and severity of...
-
DS1025 Enters Clinical Development in Patients with Advanced Solid Tumors as Novel CD25 Directed ADC in Industry-Leading ADC Portfolio of Daiichi Sankyo
TOKYO--(BUSINESS WIRE)--The first patient has been dosed in a first-in-human phase 1 trial evaluating DS1025 in adult patients with advanced or metastatic solid tumors with disease progression on or after at least one prior line of standard therapy. DS1025 is a specifically engineered, investigational, potential first-in-class CD25 directed antibody drug conjugate (ADC) containing an immuno-oncology optimized cytotoxic payload discovered by Daiichi Sankyo (TSE:4568). CD25 is a cell surface prot...
-
ActiveCampaign Launches Active Intelligence: Wavelength, Marketing AI Tuned to Your Business, Not the Industry Average
CHICAGO--(BUSINESS WIRE)--Most marketers now have AI. Almost none have AI that knows their business. Even after mass adoption, 84% of marketers still run generic campaigns built on industry best practices instead of their own data. Today, ActiveCampaign launched Active Intelligence: Wavelength, the release that closes that gap. It learns from each business’ account history, performance patterns, and customer data with over 500 signals behind every recommendation, and then acts on what it learns...
-
Otovo to Acquire PV Hawaii and Mr. Elektro for USD 4.6 Million, Expanding in the U.S. and Europe
OSLO, Norway--(BUSINESS WIRE)--Otovo ASA (Euronext Oslo Børs: OTOVO; “Otovo”), a leading provider of behind-the-meter energy services for homes and businesses, today announced it has entered into two non-binding letters of intent (LOIs) to acquire (i) PV Hawaii, LLC (“PV Hawaii”), a solar operations and maintenance provider based on Oahu, and (ii) Mr. Elektro AS (“Mr. Elektro”), a Norwegian solar and electrical contractor for a combined purchase price of approximately USD 4.6 million. These acq...
-
Standard Nuclear Announces Fuel Supply Agreement with Antares Nuclear, Inc.
OAK RIDGE, Tenn.--(BUSINESS WIRE)--Standard Nuclear (NYSE: STDN) ("Standard Nuclear" or the "Company"), a reactor-agnostic producer of TRISO nuclear fuel and the only U.S. company with industrial-scale TRISO fuel fabrication facilities, today announced the execution of a binding fuel supply agreement ("FSA") for supply of TRISO fuel with Antares Nuclear, Inc. ("Antares"), a nuclear fission energy company developing microreactors for defense and space applications. As part of the FSA, Standard N...
-
Performance Food Group Company to Participate in the Barclays 19th Annual Global Consumer Conference
RICHMOND, Va.--(BUSINESS WIRE)--Performance Food Group Company to Participate in the
Barclays 19th Annual Global Consumer Conference...
-
Astrum Space Inc to Go Public Through Business Combination With Black Spade Acquisition III Co
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Astrum Space Inc (“Astrum” or the “Company”), a satellite communications company developing a wholesale satellite-to-device (“S2D”) broadcast and data-distribution network, and Black Spade Acquisition III Co (NYSE: BIII, “BIII”) announced today that they have entered into a business combination agreement. Upon the completion of the transactions contemplated by the business combination agreement, the combined company will be renamed as “Astrum Space Company”...
-
Cyclic Materials Announces USD $75 Million Strategic Growth Financing to Scale U.S. Rare Earth Production
MESA, Ariz. & MCBEE, S.C.--(BUSINESS WIRE)--Cyclic Materials, the company building rare earth production infrastructure through circular supply chains, today announced the completion of a USD $75 million strategic financing round, reflecting expanded commitments from existing investors and bringing total equity funding to USD $237 million. The capital will accelerate deployment of Cyclic Materials’ rare earth recycling campus in South Carolina and expansion of its Hub-and-Spoke infrastructure a...